BG61812B1 - Комплекси на 3-морфолино-сиднонимин с включения - Google Patents

Комплекси на 3-морфолино-сиднонимин с включения Download PDF

Info

Publication number
BG61812B1
BG61812B1 BG95530A BG9553091A BG61812B1 BG 61812 B1 BG61812 B1 BG 61812B1 BG 95530 A BG95530 A BG 95530A BG 9553091 A BG9553091 A BG 9553091A BG 61812 B1 BG61812 B1 BG 61812B1
Authority
BG
Bulgaria
Prior art keywords
cyclodextrin
sin
morpholino
complex
salt
Prior art date
Application number
BG95530A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG95530A (bg
Inventor
Maria Vikmon
Jozsef Szejtli
Lajos Szente
Jozsef Gaal
Istvan Hermecz
Agnes Horvath
Katalin Marmorosi
Gabor Horvath
Iren Munkacsi
Original Assignee
Therabel Industries Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Industries Sa filed Critical Therabel Industries Sa
Publication of BG95530A publication Critical patent/BG95530A/bg
Publication of BG61812B1 publication Critical patent/BG61812B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG95530A 1990-03-28 1991-11-27 Комплекси на 3-морфолино-сиднонимин с включения BG61812B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901869A HU212730B (en) 1990-03-28 1990-03-28 Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
PCT/HU1991/000013 WO1991014681A1 (en) 1990-03-28 1991-03-28 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
BG95530A BG95530A (bg) 1993-12-24
BG61812B1 true BG61812B1 (bg) 1998-06-30

Family

ID=10956597

Family Applications (1)

Application Number Title Priority Date Filing Date
BG95530A BG61812B1 (bg) 1990-03-28 1991-11-27 Комплекси на 3-морфолино-сиднонимин с включения

Country Status (33)

Country Link
US (1) US5298496A (de)
EP (1) EP0478732B1 (de)
JP (1) JP2549961B2 (de)
KR (1) KR950004706B1 (de)
CN (1) CN1051081C (de)
AT (1) ATE170849T1 (de)
AU (1) AU635835B2 (de)
BG (1) BG61812B1 (de)
BR (1) BR9105137A (de)
CA (1) CA2054213C (de)
CZ (1) CZ285695B6 (de)
DE (1) DE69130146T2 (de)
DK (1) DK0478732T3 (de)
ES (1) ES2121780T3 (de)
FI (1) FI104882B (de)
GE (1) GEP19991743B (de)
HK (1) HK1011688A1 (de)
HR (1) HRP920560B1 (de)
HU (2) HU211648A9 (de)
LT (1) LT3257B (de)
LV (1) LV10087B (de)
MC (1) MC2186A1 (de)
MD (1) MD776C2 (de)
MW (1) MW6891A1 (de)
NO (1) NO303634B1 (de)
OA (1) OA09522A (de)
PL (1) PL165866B1 (de)
RO (1) RO109336B1 (de)
RU (1) RU2107695C1 (de)
SI (1) SI9110909B (de)
TJ (1) TJ189R3 (de)
UA (1) UA27242C2 (de)
WO (1) WO1991014681A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
HU213200B (en) 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
JP2003532757A (ja) * 2000-05-11 2003-11-05 イーストマン ケミカル カンパニー アシル化シクロデキストリン：ゲスト分子包接錯体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1496056A (fr) * 1964-06-08 1967-09-29 Takeda Chemical Industries Ltd Nouveaux composés chimiques du type sydnonimine
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DE3346638A1 (de) * 1983-12-23 1985-07-04 Cassella Ag, 6000 Frankfurt Photostabilisierung von molsidomin
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
WO1991015346A1 (de) * 1990-04-06 1991-10-17 Gerhard Blatt Anlage zur behandlung von betonsteinen

Also Published As

Publication number Publication date
CZ85291A3 (en) 1993-11-17
CA2054213C (en) 1998-12-01
BR9105137A (pt) 1992-08-04
AU635835B2 (en) 1993-04-01
EP0478732A1 (de) 1992-04-08
HRP920560B1 (en) 1999-12-31
PL293020A1 (en) 1992-12-28
PL165866B1 (pl) 1995-02-28
CA2054213A1 (en) 1991-09-29
RU2107695C1 (ru) 1998-03-27
ATE170849T1 (de) 1998-09-15
DE69130146T2 (de) 1999-04-01
WO1991014681A1 (en) 1991-10-03
US5298496A (en) 1994-03-29
ES2121780T3 (es) 1998-12-16
EP0478732B1 (de) 1998-09-09
LV10087A (lv) 1994-05-10
FI915570A0 (fi) 1991-11-26
HK1011688A1 (en) 1999-07-16
MC2186A1 (fr) 1992-09-16
MD940334A (en) 1996-10-31
OA09522A (en) 1992-11-15
HUT58110A (en) 1992-01-28
SI9110909A (sl) 1998-06-30
MW6891A1 (en) 1993-07-14
JP2549961B2 (ja) 1996-10-30
NO914650D0 (no) 1991-11-27
SI9110909B (sl) 1999-02-28
HU211648A9 (en) 1995-12-28
CN1055928A (zh) 1991-11-06
GEP19991743B (en) 1999-09-10
LT3257B (en) 1995-05-25
TJ189R3 (en) 1998-10-28
BG95530A (bg) 1993-12-24
HRP920560A2 (hr) 1994-04-30
NO303634B1 (no) 1998-08-10
JPH04506221A (ja) 1992-10-29
MD776C2 (ro) 1998-05-31
FI104882B (fi) 2000-04-28
KR920701183A (ko) 1992-08-11
KR950004706B1 (ko) 1995-05-04
MD776B2 (en) 1997-07-31
HU901869D0 (en) 1990-07-28
CN1051081C (zh) 2000-04-05
DE69130146D1 (de) 1998-10-15
UA27242C2 (uk) 2000-08-15
HU212730B (en) 1996-10-28
NO914650L (no) 1991-11-27
DK0478732T3 (da) 1999-06-07
CZ285695B6 (cs) 1999-10-13
RO109336B1 (ro) 1995-01-30
AU7549391A (en) 1991-10-21
LTIP387A (en) 1994-09-25
LV10087B (en) 1995-02-20

Similar Documents

Publication Publication Date Title
KR950002883B1 (ko) 발포성 커플의 제조방법
FI65441C (fi) Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin
FI67390B (fi) Foerfarande foer framstaellning av en inklusionskomplex av n-(1-fenyletyl)-3,3-difenylpropylamin eller dess hydroklorid me cyklodextrin
JPS62103077A (ja) シクロデキストリンにより形成された７−イソプロポキシ−イソフラボンの包接複合体、その製造方法および活性成分として該化合物を含有する医薬組成物
BG61812B1 (bg) Комплекси на 3-морфолино-сиднонимин с включения
JPH08511009A (ja) ジクロフェナックを含有する経口固体剤形の製造方法
RU2111216C1 (ru) Комплекс включения n-этоксикарбонил-3-морфолинсиднонимина или его соли с циклодекстрином или производным циклодекстрина, способ получения этого комплекса включения, фармацевтические композиции и способ их получения, способ лечения
RU2240784C1 (ru) Лекарственное средство на основе арбидола
EP3897729A1 (de) Zusammensetzung mit verzögerter freisetzung mit einer methylcellulose
SK278809B6 (sk) Inklúzny komplex 3-morfolinosydnonimínu alebo jeho
EA031596B1 (ru) Противоопухолевая фармацевтическая композиция, содержащая темозоломид, и способ ее получения
TW426527B (en) Cinolone composition